97 related articles for article (PubMed ID: 2805338)
1. Partial purification and characterization of CA19-9 antigen from the ascitic fluid of a patient with pancreatic cancer.
Haga Y; Horiuchi S; Morino Y; Akagi M
Clin Biochem; 1989 Oct; 22(5):363-8. PubMed ID: 2805338
[TBL] [Abstract][Full Text] [Related]
2. Isolation of glycoprotein antigen from ascites fluid of pancreatic carcinoma.
Chu TM; Holyoke ED; Douglass HO
Cancer Res; 1977 May; 37(5):1525-9. PubMed ID: 856467
[TBL] [Abstract][Full Text] [Related]
3. Preparation and partial characterization of a pancreatic cancer-associated glycoprotein expressing CA50.
Kawa S; Kato M; Oguchi H; Kobayashi T; Hsue GL; Koiwai T; Aoki Y; Furuta S; Kanai M
Scand J Gastroenterol; 1991 Dec; 26(12):1307-18. PubMed ID: 1662409
[TBL] [Abstract][Full Text] [Related]
4. Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen MUSE11.
Ban T; Imai K; Yachi A
Cancer Res; 1989 Dec; 49(24 Pt 1):7141-6. PubMed ID: 2479476
[TBL] [Abstract][Full Text] [Related]
5. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
6. Purification and immunochemical characterization of ascitic fluid glycoproteins containing certain tumor-associated and blood group antigen markers.
Venegas M; Liu L; Lovell L; Davis LE; Anderson B; Wilbanks T; Hass M; Manderino G; Rittenhouse H
Glycoconj J; 1989; 6(4):511-24. PubMed ID: 2535497
[TBL] [Abstract][Full Text] [Related]
7. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
Kobayashi H; Ohi H; Shinohara H; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
[TBL] [Abstract][Full Text] [Related]
8. A simple procedure for isolation of tumor-associated antigens by affinity chromatography using fucose-specific Aleuria aurantia lectin.
Yazawa S; Kochibe N; Asao T
Immunol Invest; 1990 Aug; 19(4):319-27. PubMed ID: 2210805
[TBL] [Abstract][Full Text] [Related]
9. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
Haglund C
Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
Kawa S; Kato M; Oguchi H; Hsue GL; Kobayashi T; Koiwai T; Tokoo M; Furuta S; Ichikawa T; Kanai M
Scand J Gastroenterol; 1992 Aug; 27(8):635-43. PubMed ID: 1359630
[TBL] [Abstract][Full Text] [Related]
11. Preparation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
Kawa S; Kato M; Oguchi H; Kobayashi T; Furuta S; Kanai M
Scand J Gastroenterol; 1991 Sep; 26(9):981-92. PubMed ID: 1682994
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of the CA 125 tumor-associated antigen from human ascites.
de los Frailes MT; Stark S; Jaeger W; Hoerauf A; Wildt L
Tumour Biol; 1993; 14(1):18-29. PubMed ID: 7684153
[TBL] [Abstract][Full Text] [Related]
13. Isolation, characterization and clinical evaluation of a pancreas cancer-associated antigen.
Shimano T; Loor RM; Papsidero LD; Kuriyama M; Vincent RG; Nemoto T; Holyoke ED; Berjian R; Douglass HO; Chu TM
Cancer; 1981 Mar; 47(6 Suppl):1602-13. PubMed ID: 7023647
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum CA125 values in patients with cancers of the digestive system.
Haga Y; Sakamoto K; Egami H; Yoshimura R; Mori K; Akagi M
Am J Med Sci; 1986 Jul; 292(1):30-4. PubMed ID: 3459357
[TBL] [Abstract][Full Text] [Related]
15. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
17. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
[TBL] [Abstract][Full Text] [Related]
18. [Heterogeneity of CA 125 antigens released from human endometrial heterotopic epithelium and ovarian cancer].
Kobayashi H; Ida W; Fujii T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):571-6. PubMed ID: 1619316
[TBL] [Abstract][Full Text] [Related]
19. Identification of a macromolecule containing an anticarcinoembryonic antigen-reactive substance and immunoglobulin M in human pancreatic cancer.
Harvey SR; Van Dusen LR; Douglass HO; Holyoke ED; Chu TM
J Natl Cancer Inst; 1978 Nov; 61(5):1199-204. PubMed ID: 280707
[TBL] [Abstract][Full Text] [Related]
20. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.
Huang T; Jiang SW; Qin L; Senkowski C; Lyle C; Terry K; Brower S; Chen H; Glasgow W; Wei Y; Li J
Int J Mol Sci; 2015 Jan; 16(2):2956-70. PubMed ID: 25642754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
